Chapter/Section Purchase

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chimeric Antigen Receptor Cell Therapy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Monotherapy
1.2.3 Combination Therapy
1.3 Market by Application
1.3.1 Global Chimeric Antigen Receptor Cell Therapy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Acute Leukemia
1.3.3 Non-hodgkin's Lymphoma
1.3.4 Multiple Myeloma
1.3.5 Transplant Rejection
1.3.6 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Chimeric Antigen Receptor Cell Therapy Market Perspective (2017-2028)
2.2 Chimeric Antigen Receptor Cell Therapy Growth Trends by Region
2.2.1 Chimeric Antigen Receptor Cell Therapy Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Chimeric Antigen Receptor Cell Therapy Historic Market Size by Region (2017-2022)
2.2.3 Chimeric Antigen Receptor Cell Therapy Forecasted Market Size by Region (2023-2028)
2.3 Chimeric Antigen Receptor Cell Therapy Market Dynamics
2.3.1 Chimeric Antigen Receptor Cell Therapy Industry Trends
2.3.2 Chimeric Antigen Receptor Cell Therapy Market Drivers
2.3.3 Chimeric Antigen Receptor Cell Therapy Market Challenges
2.3.4 Chimeric Antigen Receptor Cell Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Chimeric Antigen Receptor Cell Therapy Players by Revenue
3.1.1 Global Top Chimeric Antigen Receptor Cell Therapy Players by Revenue (2017-2022)
3.1.2 Global Chimeric Antigen Receptor Cell Therapy Revenue Market Share by Players (2017-2022)
3.2 Global Chimeric Antigen Receptor Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Chimeric Antigen Receptor Cell Therapy Revenue
3.4 Global Chimeric Antigen Receptor Cell Therapy Market Concentration Ratio
3.4.1 Global Chimeric Antigen Receptor Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Chimeric Antigen Receptor Cell Therapy Revenue in 2021
3.5 Chimeric Antigen Receptor Cell Therapy Key Players Head office and Area Served
3.6 Key Players Chimeric Antigen Receptor Cell Therapy Product Solution and Service
3.7 Date of Enter into Chimeric Antigen Receptor Cell Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Chimeric Antigen Receptor Cell Therapy Breakdown Data by Type
4.1 Global Chimeric Antigen Receptor Cell Therapy Historic Market Size by Type (2017-2022)
4.2 Global Chimeric Antigen Receptor Cell Therapy Forecasted Market Size by Type (2023-2028)
5 Chimeric Antigen Receptor Cell Therapy Breakdown Data by Application
5.1 Global Chimeric Antigen Receptor Cell Therapy Historic Market Size by Application (2017-2022)
5.2 Global Chimeric Antigen Receptor Cell Therapy Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Chimeric Antigen Receptor Cell Therapy Market Size (2017-2028)
6.2 North America Chimeric Antigen Receptor Cell Therapy Market Size by Type
6.2.1 North America Chimeric Antigen Receptor Cell Therapy Market Size by Type (2017-2022)
6.2.2 North America Chimeric Antigen Receptor Cell Therapy Market Size by Type (2023-2028)
6.2.3 North America Chimeric Antigen Receptor Cell Therapy Market Share by Type (2017-2028)
6.3 North America Chimeric Antigen Receptor Cell Therapy Market Size by Application
6.3.1 North America Chimeric Antigen Receptor Cell Therapy Market Size by Application (2017-2022)
6.3.2 North America Chimeric Antigen Receptor Cell Therapy Market Size by Application (2023-2028)
6.3.3 North America Chimeric Antigen Receptor Cell Therapy Market Share by Application (2017-2028)
6.4 North America Chimeric Antigen Receptor Cell Therapy Market Size by Country
6.4.1 North America Chimeric Antigen Receptor Cell Therapy Market Size by Country (2017-2022)
6.4.2 North America Chimeric Antigen Receptor Cell Therapy Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Chimeric Antigen Receptor Cell Therapy Market Size (2017-2028)
7.2 Europe Chimeric Antigen Receptor Cell Therapy Market Size by Type
7.2.1 Europe Chimeric Antigen Receptor Cell Therapy Market Size by Type (2017-2022)
7.2.2 Europe Chimeric Antigen Receptor Cell Therapy Market Size by Type (2023-2028)
7.2.3 Europe Chimeric Antigen Receptor Cell Therapy Market Share by Type (2017-2028)
7.3 Europe Chimeric Antigen Receptor Cell Therapy Market Size by Application
7.3.1 Europe Chimeric Antigen Receptor Cell Therapy Market Size by Application (2017-2022)
7.3.2 Europe Chimeric Antigen Receptor Cell Therapy Market Size by Application (2023-2028)
7.3.3 Europe Chimeric Antigen Receptor Cell Therapy Market Share by Application (2017-2028)
7.4 Europe Chimeric Antigen Receptor Cell Therapy Market Size by Country
7.4.1 Europe Chimeric Antigen Receptor Cell Therapy Market Size by Country (2017-2022)
7.4.2 Europe Chimeric Antigen Receptor Cell Therapy Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Chimeric Antigen Receptor Cell Therapy Market Size (2017-2028)
8.2 Asia-Pacific Chimeric Antigen Receptor Cell Therapy Market Size by Type
8.2.1 Asia-Pacific Chimeric Antigen Receptor Cell Therapy Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Chimeric Antigen Receptor Cell Therapy Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Chimeric Antigen Receptor Cell Therapy Market Share by Type (2017-2028)
8.3 Asia-Pacific Chimeric Antigen Receptor Cell Therapy Market Size by Application
8.3.1 Asia-Pacific Chimeric Antigen Receptor Cell Therapy Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Chimeric Antigen Receptor Cell Therapy Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Chimeric Antigen Receptor Cell Therapy Market Share by Application (2017-2028)
8.4 Asia-Pacific Chimeric Antigen Receptor Cell Therapy Market Size by Region
8.4.1 Asia-Pacific Chimeric Antigen Receptor Cell Therapy Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Chimeric Antigen Receptor Cell Therapy Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Chimeric Antigen Receptor Cell Therapy Market Size (2017-2028)
9.2 Latin America Chimeric Antigen Receptor Cell Therapy Market Size by Type
9.2.1 Latin America Chimeric Antigen Receptor Cell Therapy Market Size by Type (2017-2022)
9.2.2 Latin America Chimeric Antigen Receptor Cell Therapy Market Size by Type (2023-2028)
9.2.3 Latin America Chimeric Antigen Receptor Cell Therapy Market Share by Type (2017-2028)
9.3 Latin America Chimeric Antigen Receptor Cell Therapy Market Size by Application
9.3.1 Latin America Chimeric Antigen Receptor Cell Therapy Market Size by Application (2017-2022)
9.3.2 Latin America Chimeric Antigen Receptor Cell Therapy Market Size by Application (2023-2028)
9.3.3 Latin America Chimeric Antigen Receptor Cell Therapy Market Share by Application (2017-2028)
9.4 Latin America Chimeric Antigen Receptor Cell Therapy Market Size by Country
9.4.1 Latin America Chimeric Antigen Receptor Cell Therapy Market Size by Country (2017-2022)
9.4.2 Latin America Chimeric Antigen Receptor Cell Therapy Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size (2017-2028)
10.2 Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size by Type
10.2.1 Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Share by Type (2017-2028)
10.3 Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size by Application
10.3.1 Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Share by Application (2017-2028)
10.4 Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size by Country
10.4.1 Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Amgen Inc
11.1.1 Amgen Inc Company Details
11.1.2 Amgen Inc Business Overview
11.1.3 Amgen Inc Chimeric Antigen Receptor Cell Therapy Introduction
11.1.4 Amgen Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
11.1.5 Amgen Inc Recent Developments
11.2 Autolus Therapeutics Plc
11.2.1 Autolus Therapeutics Plc Company Details
11.2.2 Autolus Therapeutics Plc Business Overview
11.2.3 Autolus Therapeutics Plc Chimeric Antigen Receptor Cell Therapy Introduction
11.2.4 Autolus Therapeutics Plc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
11.2.5 Autolus Therapeutics Plc Recent Developments
11.3 Beijing Immunochina Medical Science & Technology Co Ltd
11.3.1 Beijing Immunochina Medical Science & Technology Co Ltd Company Details
11.3.2 Beijing Immunochina Medical Science & Technology Co Ltd Business Overview
11.3.3 Beijing Immunochina Medical Science & Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Introduction
11.3.4 Beijing Immunochina Medical Science & Technology Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
11.3.5 Beijing Immunochina Medical Science & Technology Co Ltd Recent Developments
11.4 Bellicum Pharmaceuticals Inc
11.4.1 Bellicum Pharmaceuticals Inc Company Details
11.4.2 Bellicum Pharmaceuticals Inc Business Overview
11.4.3 Bellicum Pharmaceuticals Inc Chimeric Antigen Receptor Cell Therapy Introduction
11.4.4 Bellicum Pharmaceuticals Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
11.4.5 Bellicum Pharmaceuticals Inc Recent Developments
11.5 Bristol-Myers Squibb Co
11.5.1 Bristol-Myers Squibb Co Company Details
11.5.2 Bristol-Myers Squibb Co Business Overview
11.5.3 Bristol-Myers Squibb Co Chimeric Antigen Receptor Cell Therapy Introduction
11.5.4 Bristol-Myers Squibb Co Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
11.5.5 Bristol-Myers Squibb Co Recent Developments
11.6 bluebird bio Inc
11.6.1 bluebird bio Inc Company Details
11.6.2 bluebird bio Inc Business Overview
11.6.3 bluebird bio Inc Chimeric Antigen Receptor Cell Therapy Introduction
11.6.4 bluebird bio Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
11.6.5 bluebird bio Inc Recent Developments
11.7 CARsgen Therapeutics Ltd
11.7.1 CARsgen Therapeutics Ltd Company Details
11.7.2 CARsgen Therapeutics Ltd Business Overview
11.7.3 CARsgen Therapeutics Ltd Chimeric Antigen Receptor Cell Therapy Introduction
11.7.4 CARsgen Therapeutics Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
11.7.5 CARsgen Therapeutics Ltd Recent Developments
11.8 Celgene Corp
11.8.1 Celgene Corp Company Details
11.8.2 Celgene Corp Business Overview
11.8.3 Celgene Corp Chimeric Antigen Receptor Cell Therapy Introduction
11.8.4 Celgene Corp Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
11.8.5 Celgene Corp Recent Developments
11.9 Cell Medica Ltd
11.9.1 Cell Medica Ltd Company Details
11.9.2 Cell Medica Ltd Business Overview
11.9.3 Cell Medica Ltd Chimeric Antigen Receptor Cell Therapy Introduction
11.9.4 Cell Medica Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
11.9.5 Cell Medica Ltd Recent Developments
11.10 Cellular Biomedicine Group Inc
11.10.1 Cellular Biomedicine Group Inc Company Details
11.10.2 Cellular Biomedicine Group Inc Business Overview
11.10.3 Cellular Biomedicine Group Inc Chimeric Antigen Receptor Cell Therapy Introduction
11.10.4 Cellular Biomedicine Group Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
11.10.5 Cellular Biomedicine Group Inc Recent Developments
11.11 Celularity Inc
11.11.1 Celularity Inc Company Details
11.11.2 Celularity Inc Business Overview
11.11.3 Celularity Inc Chimeric Antigen Receptor Cell Therapy Introduction
11.11.4 Celularity Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
11.11.5 Celularity Inc Recent Developments
11.12 Celyad SA
11.12.1 Celyad SA Company Details
11.12.2 Celyad SA Business Overview
11.12.3 Celyad SA Chimeric Antigen Receptor Cell Therapy Introduction
11.12.4 Celyad SA Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
11.12.5 Celyad SA Recent Developments
11.13 Daiichi Sankyo Co Ltd
11.13.1 Daiichi Sankyo Co Ltd Company Details
11.13.2 Daiichi Sankyo Co Ltd Business Overview
11.13.3 Daiichi Sankyo Co Ltd Chimeric Antigen Receptor Cell Therapy Introduction
11.13.4 Daiichi Sankyo Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
11.13.5 Daiichi Sankyo Co Ltd Recent Developments
11.14 Fosun Pharmaceutical AG
11.14.1 Fosun Pharmaceutical AG Company Details
11.14.2 Fosun Pharmaceutical AG Business Overview
11.14.3 Fosun Pharmaceutical AG Chimeric Antigen Receptor Cell Therapy Introduction
11.14.4 Fosun Pharmaceutical AG Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
11.14.5 Fosun Pharmaceutical AG Recent Developments
11.15 Gilead Sciences Inc
11.15.1 Gilead Sciences Inc Company Details
11.15.2 Gilead Sciences Inc Business Overview
11.15.3 Gilead Sciences Inc Chimeric Antigen Receptor Cell Therapy Introduction
11.15.4 Gilead Sciences Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
11.15.5 Gilead Sciences Inc Recent Developments
11.16 Guangzhou Anjie Biomedical Technology Co Ltd
11.16.1 Guangzhou Anjie Biomedical Technology Co Ltd Company Details
11.16.2 Guangzhou Anjie Biomedical Technology Co Ltd Business Overview
11.16.3 Guangzhou Anjie Biomedical Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Introduction
11.16.4 Guangzhou Anjie Biomedical Technology Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
11.16.5 Guangzhou Anjie Biomedical Technology Co Ltd Recent Developments
11.17 Hangzhou Converd Co Ltd
11.17.1 Hangzhou Converd Co Ltd Company Details
11.17.2 Hangzhou Converd Co Ltd Business Overview
11.17.3 Hangzhou Converd Co Ltd Chimeric Antigen Receptor Cell Therapy Introduction
11.17.4 Hangzhou Converd Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
11.17.5 Hangzhou Converd Co Ltd Recent Developments
11.18 Hebei Senlang Biotechnology Inc Ltd
11.18.1 Hebei Senlang Biotechnology Inc Ltd Company Details
11.18.2 Hebei Senlang Biotechnology Inc Ltd Business Overview
11.18.3 Hebei Senlang Biotechnology Inc Ltd Chimeric Antigen Receptor Cell Therapy Introduction
11.18.4 Hebei Senlang Biotechnology Inc Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
11.18.5 Hebei Senlang Biotechnology Inc Ltd Recent Developments
11.19 HRAIN Biotechnology Co Ltd
11.19.1 HRAIN Biotechnology Co Ltd Company Details
11.19.2 HRAIN Biotechnology Co Ltd Business Overview
11.19.3 HRAIN Biotechnology Co Ltd Chimeric Antigen Receptor Cell Therapy Introduction
11.19.4 HRAIN Biotechnology Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
11.19.5 HRAIN Biotechnology Co Ltd Recent Developments
11.20 Juno Therapeutics Inc
11.20.1 Juno Therapeutics Inc Company Details
11.20.2 Juno Therapeutics Inc Business Overview
11.20.3 Juno Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Introduction
11.20.4 Juno Therapeutics Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
11.20.5 Juno Therapeutics Inc Recent Developments
11.21 Kite Pharma Inc
11.21.1 Kite Pharma Inc Company Details
11.21.2 Kite Pharma Inc Business Overview
11.21.3 Kite Pharma Inc Chimeric Antigen Receptor Cell Therapy Introduction
11.21.4 Kite Pharma Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
11.21.5 Kite Pharma Inc Recent Developments
11.22 Nanjing Legend Biotech Co Ltd
11.22.1 Nanjing Legend Biotech Co Ltd Company Details
11.22.2 Nanjing Legend Biotech Co Ltd Business Overview
11.22.3 Nanjing Legend Biotech Co Ltd Chimeric Antigen Receptor Cell Therapy Introduction
11.22.4 Nanjing Legend Biotech Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
11.22.5 Nanjing Legend Biotech Co Ltd Recent Developments
11.23 NantKwest Inc
11.23.1 NantKwest Inc Company Details
11.23.2 NantKwest Inc Business Overview
11.23.3 NantKwest Inc Chimeric Antigen Receptor Cell Therapy Introduction
11.23.4 NantKwest Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
11.23.5 NantKwest Inc Recent Developments
11.24 Nkarta Inc
11.24.1 Nkarta Inc Company Details
11.24.2 Nkarta Inc Business Overview
11.24.3 Nkarta Inc Chimeric Antigen Receptor Cell Therapy Introduction
11.24.4 Nkarta Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
11.24.5 Nkarta Inc Recent Developments
11.25 Novartis AG
11.25.1 Novartis AG Company Details
11.25.2 Novartis AG Business Overview
11.25.3 Novartis AG Chimeric Antigen Receptor Cell Therapy Introduction
11.25.4 Novartis AG Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
11.25.5 Novartis AG Recent Developments
11.26 Ono Pharmaceutical Co Ltd
11.26.1 Ono Pharmaceutical Co Ltd Company Details
11.26.2 Ono Pharmaceutical Co Ltd Business Overview
11.26.3 Ono Pharmaceutical Co Ltd Chimeric Antigen Receptor Cell Therapy Introduction
11.26.4 Ono Pharmaceutical Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
11.26.5 Ono Pharmaceutical Co Ltd Recent Developments
11.27 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd
11.27.1 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Company Details
11.27.2 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Business Overview
11.27.3 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Introduction
11.27.4 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
11.27.5 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Recent Developments
11.28 Sorrento Therapeutics Inc
11.28.1 Sorrento Therapeutics Inc Company Details
11.28.2 Sorrento Therapeutics Inc Business Overview
11.28.3 Sorrento Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Introduction
11.28.4 Sorrento Therapeutics Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
11.28.5 Sorrento Therapeutics Inc Recent Developments
11.29 Takara Bio Inc
11.29.1 Takara Bio Inc Company Details
11.29.2 Takara Bio Inc Business Overview
11.29.3 Takara Bio Inc Chimeric Antigen Receptor Cell Therapy Introduction
11.29.4 Takara Bio Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2017-2022)
11.29.5 Takara Bio Inc Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer